Kaul, Sanjay

Cardiovascular and renal outcomes with empagliflozin in heart failure

Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine

Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 5,206

Good Enough: A Primer on the Analysis and Interpretation of Noninferiority Trials

Kaul, S., & Diamond, G. A. (2006) · Annals of Internal Medicine

Statistical Methods in Clinical TrialsPharmaceutical studies and practices

Cited by 272

Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-Analysis

Sackner-Bernstein, J., Kanter, D., & Kaul, S. (2015) · PLOS ONE

Diet and metabolism studiesDietary Effects on Health

Cited by 220

The cardiovascular safety of diabetes drugs–insights from the rosiglitazone experience

Hiatt, W. R., Kaul, S., & Smith, R. J. (2013) · New England Journal of Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 204

Impact of High Volume Energy Drink Consumption on Electrocardiographic and Blood Pressure Parameters: A Randomized Trial

Shah, S. A., Szeto, A. H., Farewell, R., Shek, A., Fan, D., Quach, K. N., Bhattacharyya, M., Elmiari, J., Chan, W., O'Dell, K., et al. (2019) · Journal of the American Heart Association

Coffee research and impactsCardiac electrophysiology and arrhythmias

Cited by 111

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 109

Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials

Kaul, S. (2017) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 62